The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has said it will launch a pilot programme in the coming weeks to see how it can evolve the regulation of artificial ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced the five technologies selected to participate in the ‘AI Airlock Pilot’ for AI-powered medical devices. The pilot is a ...
Access to first-in-class medicinal products that can save and transform lives is crucial for patients in the UK – and the earlier the access, the ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has licensed an indication extension to Blincyto ...
Aurobindo Pharma shares jumped 2% to an intraday high of Rs 1,265 on the BSE after its wholly owned step-down subsidiary ...
UK MHRA grants conditional marketing authorisation to Italfarmaco’s givinostat to treat patients with Duchenne muscular dystrophy: United Kingdom Tuesday, December 24, 2024, 12: ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing ...
(RTTNews) - Rhythm Pharmaceuticals (RYTM) announced that the United Kingdoms Medicines & Healthcare products Regulatory Agency or MHRA has expanded the marketing authorization for IMCIVREE or ...
2024年12月6日， 万脉医疗成功获得英国 MHRA注册！ 这意味着，万脉医疗系列产品不仅可以在英国本土销售，还能在认可英国MHRA注册的国家市场上占据一席之地，为更多患者带去健康与希望。 英国 MHRA注册 ...
The approval by the DoH of Hong Kong constitutes the fifth independent approval by local health authorities after the US FDA, EMEA, MHRA and the NMPA and will allow patients with DMD in Hong Kong ...
Hyderabad: CuraTeQ Biologics s.r.o., a step-down subsidiary of Aurobindo Pharma Limited, has announced that it has obtained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback